Angiotech Pharmaceuticals, Inc. is a global specialty pharmaceutical and medical device company with over 1,500 dedicated employees. Angiotech discovers, develops and markets innovative treatment solutions for diseases or complications associated with medical device implants, surgical interventions and acute injury. To find out more about Angiotech (NASDAQ: ANPI, TSX: ANP), please visit our website at www.angiotech.com.

Contact Information

1618 Station Street
Vancouver, BCV6A1B6

tel: 604-221-7676
fax: 604-221-2330


Investor Relations



Exchange: NASDAQ
Industry: Drug Manufacturers - Other
Market Cap: $243.4M

The information provided here has been obtained from publicly available sources as well as directly from issuers in some cases. Please see our Disclaimer and Terms of Service for more information.